Physician profile
Scott Wheeler
NPI 1104891654
$1,565.02
in general payments reported to CMS, 2019-2025
20 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,025 · 2022: $230 · 2024: $129 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $262.45 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $219.59 | 2021 | |
| Abbvie INC. | $163.91 | 2021-2024 | |
| Amgen INC. | $147.27 | 2021-2025 | Krystexxa |
| Stryker Corporation | $112.45 | 2022 | |
| Medtronic, INC. | $108.55 | 2021 | |
| Boston Scientific Corporation | $93.60 | 2021-2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $60.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $49.48 | 2021 | |
| Scilex Pharmaceuticals INC. | $46.87 | 2021 | |
| Si-Bone, INC. | $44.94 | 2021 | |
| Abbott Laboratories | $40.44 | 2021 | |
| Bioventus LLC | $39.56 | 2024 | Durolane |
| Biohaven Pharmaceuticals, INC. | $33.72 | 2021 | |
| Pfizer INC. | $31.82 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $29.12 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $24.39 | 2024 | Libtayo |
| Redhill Biopharma INC. | $22.51 | 2021 | |
| Radius Health, INC. | $20.41 | 2021 | |
| Hikma Pharmaceuticals USA | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.